![](/img/cover-not-exists.png)
MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis
Uccelli, Antonio, Laroni, Alice, Brundin, Lou, Clanet, Michel, Fernandez, Oscar, Nabavi, Seyed Massood, Muraro, Paolo A., Oliveri, Roberto S., Radue, Ernst W., Sellner, Johann, Soelberg Sorensen, Per,Volume:
20
Language:
english
Journal:
Trials
DOI:
10.1186/s13063-019-3346-z
Date:
December, 2019
File:
PDF, 870 KB
english, 2019